Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells

Virology

Volumn 276, Issue 1, 2000, Pages 214-226

  Meyer, Keith ^a   Basu, Arnab ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CONCANAVALIN A; HEPARIN; LECTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE BINDING PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CHIMERA; CHIMPANZEE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0034633826     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0547     Document Type: Article

References (85)

1. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets
2. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
3. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
4. The natural history of community acquired hepatitis C in the United States
5. Hepatitis C virus structural proteins assemble into virus lile particles in insect cells
6. Monoclonal antibodies to the low density lipoprotein receptor-mediated endocytosis and the genetics of familial hypercholesterolemia
7. 0 precursor proteins for this alternative route of cell entry
8. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. 1998
9. Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells
10. LDL-receptor structure. Calcium cages, acid baths and recycling receptors
11. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
12. Genetic organization and diversity of the hepatitis C virus
13. Vaccination of chimpanzees against infection by the hepatitis C virus
14. Characterization of aggregates of hepatitis C virus glycoproteins
15. Pseudotypes of human T-cell leukemia virus types 1 and 2: Neutralization by patients' sera
16. The transmembrane domain in viral fusion: Essential role for a conserved glycine residue vesicular stomatitis virus G protein
17. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
18. Formation of native hepatitis C virus glycoprotein complexes
19. Hepatitis C virus envelope proteins: Immunogenicity in humans and their role in diagnosis and vaccine development
20. The structure of the saccharide-binding site of concanavalin A
21. Expression and characterization of a truncated, soluble, low-density lipoprotein receptor
22. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane
23. Inhibitory effect of modified Bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases
24. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses
25. The collectins in innate immunity
26. The structure and function of vertebrate mannose lectin-like proteins
27. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
28. Functional analysis of cell-surface exposed hepatitis C virus E2 glycoprotein
29. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness
30. Suramin blocks hepatitis C binding to human hepatoma cells in vitro
31. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia
32. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
33. Expression and identification of hepatitis C virus polyprotein cleavage products
34. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells
35. Virus-cell and cell-cell fusion
36. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding
37. Inhibition of pestivirus infection in cell culture by envelope proteins E(rns) and E2 of classical swine fever virus: E(rns) and E2 interact with different receptors
38. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
39. Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose density gradient centrifugation related to degree of liver inflammation
40. Resiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
41. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus
42. Paramyxovirus fusion: A hypothesis for changes
43. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells
44. Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains
45. Interaction between hepatitis C virus core protein and E1 envelope protein
46. Virus entry into animal cells
47. The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity
48. Characterization of pseudotype VSV possessing HCV envelope proteins
49. The pH independence of mammalian retrovirus infection
50. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
51. Acidification of the endocytic and exocytic pathways
52. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex
53. Extraordinary low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction
54. Low density lipoprotein receptor as a candidate receptor as a candidate receptor for hepatitis C virus
55. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
56. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G
57. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus
58. + ATPase is required for both endocytic and exocytic processes during viral infection of BHK-21 cells
59. Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2
60. Involvement of the vacuolar ATPase in animal virus entry
61. Binding of hepatitis C virus to CD81
62. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins
63. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
64. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
65. Hepatitis C virus infection associated with the development of hepatocellular carcinoma
66. Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans
67. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles
68. Inhibitors of lysosomal function
69. Complex processing and protein:protein interactions in the E2:NS2 region of HCV
70. Establishment of persistent hepatitis C virus infection and replication in vitro
71. Surface carbohydrates and surface lectins are recognition determinants in phagocytosis
72. Lectins as cell recognition molecules
73. On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride
74. Entry of alphaherpesviruses into cells
75. Distinct and overlapping functions of allelic forms of human mannose binding protein
76. Mutation of gene of mannose-binding protein associated with hepatitis B viral infection
77. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins
78. Host factors in chronic viral hepatitis
79. Clinical outcomes after transfusion associated hepatitis C
80. Intracellular and extracellular vaccinia virions enter cells by different mechanisms
81. Molecular cross talk between epithelial cells and pathogenic microorganisms
82. Receptor-mediated endocytosis
83. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2
84. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPse, inhibits acidification and protein degradation in lysosomes of cultured cells
85. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G